JANX: Janux Therapeutics Inc Financial Statements
Balance sheet, income statement, and cash flow statements for Janux Therapeutics Inc (JANX).
$2.81B Market Cap.
JANX Market Cap. (MRY)
JANX Shares Outstanding (MRY)
JANX Assets (MRY)
Total Assets
$1.06B
Total Liabilities
$38.73M
Total Investments
$594.57M
JANX Income (MRY)
Revenue
$10.59M
Net Income
-$68.99M
Operating Expense
$109.44M
JANX Cash Flow (MRY)
CF Operations
-$43.81M
CF Investing
-$258.02M
CF Financing
$713.24M
JANX Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total Assets | $1,061,516,000 (179.05%) | $380,407,000 (4.50%) | $364,010,000 (-4.16%) | $379,824,000 (2242.13%) |
Assets Current | $1,033,666,000 (195.97%) | $349,241,000 (5.05%) | $332,439,000 (-11.82%) | $377,019,000 (2247.27%) |
Assets Non-Current | $27,850,000 (-10.64%) | $31,166,000 (-1.28%) | $31,571,000 (1025.53%) | $2,805,000 (1709.68%) |
Goodwill & Intangible Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Shareholders Equity | $1,022,781,000 (197.02%) | $344,349,000 (7.36%) | $320,740,000 (-12.44%) | $366,327,000 (2602.58%) |
Property Plant & Equipment Net | $24,150,000 (-13.26%) | $27,841,000 (-5.19%) | $29,365,000 (1738.76%) | $1,597,000 (930.32%) |
Cash & Equivalents | $431,421,000 (2054.84%) | $20,021,000 (-61.68%) | $52,242,000 (43.53%) | $36,398,000 (365.86%) |
Accumulated Other Comprehensive Income | $2,163,000 (225.26%) | $665,000 (143.32%) | -$1,535,000 (-468.52%) | -$270,000 (0%) |
Deferred Revenue | $0 (0%) | $1,705,000 (-77.65%) | $7,627,000 (30.09%) | $5,863,000 (-26.71%) |
Total Investments | $594,568,000 (83.04%) | $324,823,000 (17.86%) | $275,590,000 (-18.80%) | $339,383,000 (0%) |
Investments Current | $594,568,000 (83.04%) | $324,823,000 (17.86%) | $275,590,000 (-18.80%) | $339,383,000 (0%) |
Investments Non-Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Inventory | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Receivables | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Payables | $4,026,000 (66.09%) | $2,424,000 (12.27%) | $2,159,000 (-12.16%) | $2,458,000 (474.30%) |
Accumulated Retained Earnings (Deficit) | -$237,757,000 (-40.88%) | -$168,763,000 (-52.77%) | -$110,470,000 (-133.00%) | -$47,411,000 (-221.67%) |
Tax Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Tax Liabilities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Debt | $23,025,000 (-6.18%) | $24,542,000 (-3.02%) | $25,305,000 (12943.81%) | $194,000 (0%) |
Debt Current | $1,749,000 (15.29%) | $1,517,000 (98.82%) | $763,000 (293.30%) | $194,000 (0%) |
Debt Non-Current | $21,276,000 (-7.60%) | $23,025,000 (-6.18%) | $24,542,000 (0%) | $0 (0%) |
Total Liabilities | $38,735,000 (7.42%) | $36,058,000 (-16.67%) | $43,270,000 (220.59%) | $13,497,000 (46.21%) |
Liabilities Current | $17,459,000 (33.96%) | $13,033,000 (-21.05%) | $16,507,000 (28.99%) | $12,797,000 (302.29%) |
Liabilities Non-Current | $21,276,000 (-7.60%) | $23,025,000 (-13.97%) | $26,763,000 (3723.29%) | $700,000 (-88.43%) |
JANX Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Revenues | $10,588,000 (30.99%) | $8,083,000 (-6.14%) | $8,612,000 (136.79%) | $3,637,000 (0%) |
Cost of Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Selling General & Administrative Expense | $41,047,000 (57.03%) | $26,140,000 (17.42%) | $22,262,000 (115.53%) | $10,329,000 (473.20%) |
Research & Development Expense | $68,388,000 (24.52%) | $54,922,000 (2.77%) | $53,441,000 (103.69%) | $26,237,000 (762.78%) |
Operating Expenses | $109,435,000 (35.00%) | $81,062,000 (7.08%) | $75,703,000 (107.03%) | $36,566,000 (655.03%) |
Interest Expense | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Income Tax Expense | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Consolidated Income | -$68,994,000 (-18.36%) | -$58,293,000 (7.56%) | -$63,059,000 (-93.01%) | -$32,672,000 (-381.60%) |
Net Income to Non-Controlling Interests | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income | -$68,994,000 (-18.36%) | -$58,293,000 (7.56%) | -$63,059,000 (-93.01%) | -$32,672,000 (-381.60%) |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income Common Stock | -$68,994,000 (-18.36%) | -$58,293,000 (7.56%) | -$63,059,000 (-93.01%) | -$32,672,000 (-381.60%) |
Weighted Average Shares | $53,751,480 (22.12%) | $44,016,283 (6.14%) | $41,469,631 (76.24%) | $23,530,252 (2471.20%) |
Weighted Average Shares Diluted | $53,751,480 (22.12%) | $44,016,283 (6.14%) | $41,469,631 (76.24%) | $23,530,252 (2471.20%) |
Earning Before Interest & Taxes (EBIT) | -$68,994,000 (-18.36%) | -$58,293,000 (7.56%) | -$63,059,000 (-93.01%) | -$32,672,000 (-396.69%) |
Gross Profit | $10,588,000 (30.99%) | $8,083,000 (-6.14%) | $8,612,000 (136.79%) | $3,637,000 (0%) |
Operating Income | -$98,847,000 (-35.45%) | -$72,979,000 (-8.78%) | -$67,091,000 (-103.74%) | -$32,929,000 (-579.93%) |
JANX Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Net Cash Flow from Investing | -$258,021,000 (-526.36%) | -$41,194,000 (-170.70%) | $58,266,000 (117.09%) | -$340,963,000 (0%) |
Net Cash Flow from Financing | $713,235,000 (1097.75%) | $59,548,000 (11809.60%) | $500,000 (-99.87%) | $386,524,000 (3254.08%) |
Net Cash Flow from Operations | -$43,814,000 (13.37%) | -$50,575,000 (-17.83%) | -$42,922,000 (-152.84%) | -$16,976,000 (-288.56%) |
Net Cash Flow / Change in Cash & Cash Equivalents | $411,400,000 (1376.81%) | -$32,221,000 (-303.36%) | $15,844,000 (-44.57%) | $28,585,000 (299.51%) |
Net Cash Flow - Business Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Cash Flow - Investment Acquisitions and Disposals | -$257,662,000 (-554.90%) | -$39,344,000 (-160.80%) | $64,711,000 (119.06%) | -$339,481,000 (0%) |
Capital Expenditure | -$359,000 (80.59%) | -$1,850,000 (71.30%) | -$6,445,000 (-334.89%) | -$1,482,000 (0%) |
Issuance (Repayment) of Debt Securities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Issuance (Purchase) of Equity Shares | $713,235,000 (1097.75%) | $59,548,000 (11809.60%) | $500,000 (-99.76%) | $205,977,000 (294152.86%) |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Effect of Exchange Rate Changes on Cash | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Share Based Compensation | $33,020,000 (65.06%) | $20,005,000 (16.29%) | $17,203,000 (148.96%) | $6,910,000 (9497.22%) |
Depreciation Amortization & Accretion | $2,060,000 (5.37%) | $1,955,000 (132.46%) | $841,000 (644.25%) | $113,000 (769.23%) |
JANX Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Gross Margin | 100.00% (0.00%) | 100.00% (0.00%) | 100.00% (0.00%) | 100.00% |
Profit Margin | -651.60% (9.65%) | -721.20% (1.50%) | -732.20% (18.49%) | -898.30% |
EBITDA Margin | -632.20% (9.30%) | -697.00% (3.53%) | -722.50% (19.29%) | -895.20% |
Return on Average Equity (ROAE) | -9.20% (48.60%) | -17.90% (4.28%) | -18.70% (-58.47%) | -11.80% (-119.63%) |
Return on Average Assets (ROAA) | -8.80% (45.00%) | -16.00% (5.33%) | -16.90% (-60.95%) | -10.50% (86.92%) |
Return on Sales (ROS) | -651.60% (9.65%) | -721.20% (1.50%) | -732.20% (18.49%) | -898.30% |
Return on Invested Capital (ROIC) | -11.10% (33.53%) | -16.70% (15.66%) | -19.80% (-21.47%) | -16.30% (94.28%) |
Dividend Yield | 0% (0%) | 0% (0%) | 0% (0%) | 0% |
Price to Earnings Ratio (P/E) | -41.83 (-414.55%) | -8.13 (6.17%) | -8.66 (38.96%) | -14.19 |
Price to Sales Ratio (P/S) | 271.8 (365.17%) | 58.43 (-7.86%) | 63.42 (-50.32%) | 127.65 |
Price to Book Ratio (P/B) | 2.75 (90.90%) | 1.44 (-15.90%) | 1.71 (-23.65%) | 2.24 |
Debt to Equity Ratio (D/E) | 0.04 (-63.81%) | 0.1 (-22.22%) | 0.14 (264.86%) | 0.04 (105.86%) |
Earnings Per Share (EPS) | -1.28 (3.03%) | -1.32 (13.16%) | -1.52 (-9.35%) | -1.39 (81.24%) |
Sales Per Share (SPS) | 0.2 (7.07%) | 0.18 (-11.54%) | 0.21 (34.19%) | 0.15 (0%) |
Free Cash Flow Per Share (FCFPS) | -0.82 (30.98%) | -1.19 (-0.08%) | -1.19 (-51.79%) | -0.78 (83.58%) |
Book Value Per Share (BVPS) | 19.03 (143.23%) | 7.82 (1.15%) | 7.73 (-50.32%) | 15.57 (197.33%) |
Tangible Assets Book Value Per Share (TABVPS) | 19.75 (128.52%) | 8.64 (-1.55%) | 8.78 (-45.62%) | 16.14 (-8.91%) |
Enterprise Value Over EBIT (EV/EBIT) | -41 (-355.56%) | -9 (-12.50%) | -8 (66.67%) | -24 |
Enterprise Value Over EBITDA (EV/EBITDA) | -41.92 (-370.14%) | -8.92 (-9.37%) | -8.15 (66.05%) | -24.01 |
Asset Turnover | 0.01 (-36.36%) | 0.02 (-4.35%) | 0.02 (91.67%) | 0.01 (0%) |
Current Ratio | 59.2 (120.94%) | 26.8 (33.06%) | 20.14 (-31.64%) | 29.46 (483.52%) |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | -$44,173,000 (15.74%) | -$52,425,000 (-6.19%) | -$49,367,000 (-167.46%) | -$18,458,000 (-322.48%) |
Enterprise Value (EV) | $2,805,748,351 (458.57%) | $502,312,254 (-0.97%) | $507,226,092 (-35.12%) | $781,841,092 |
Earnings Before Tax (EBT) | -$68,994,000 (-18.36%) | -$58,293,000 (7.56%) | -$63,059,000 (-93.01%) | -$32,672,000 (-381.60%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$66,934,000 (-18.81%) | -$56,338,000 (9.45%) | -$62,218,000 (-91.09%) | -$32,559,000 (-395.95%) |
Invested Capital | $635,661,000 (70.92%) | $371,895,000 (16.01%) | $320,566,000 (-3.10%) | $330,823,000 (6233.97%) |
Working Capital | $1,016,207,000 (202.26%) | $336,208,000 (6.42%) | $315,932,000 (-13.26%) | $364,222,000 (2727.59%) |
Tangible Asset Value | $1,061,516,000 (179.05%) | $380,407,000 (4.50%) | $364,010,000 (-4.16%) | $379,824,000 (2242.13%) |
Market Capitalization | $2,809,887,351 (467.21%) | $495,387,254 (-9.72%) | $548,702,092 (-33.17%) | $820,995,092 |
Average Equity | $748,081,250 (129.47%) | $326,007,500 (-3.56%) | $338,037,250 (21.69%) | $277,775,250 (2560.15%) |
Average Assets | $784,232,750 (114.61%) | $365,428,250 (-2.14%) | $373,432,000 (20.51%) | $309,887,500 (3568.18%) |
Invested Capital Average | $621,629,500 (78.03%) | $349,178,750 (9.52%) | $318,827,250 (59.33%) | $200,107,750 (8568.30%) |
Shares | 52,482,020 (13.68%) | 46,168,430 (10.81%) | 41,663,029 (0.12%) | 41,611,510 |
